SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around its listing on Bifinance and the upcoming release of a mobile app. Discussions highlight the coin's resilience, community-driven development, and potential for significant growth. The community emphasizes its unique approach and grind, attracting attention within the Solana meme coin space.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as its AI initiatives gain traction, including a major customer win for its AI chips, signaling growing domestic demand and a potential shift away from reliance on US tech. Community members are discussing price targets, Cathie Wood's renewed interest, and the potential impact of geopolitical factors on the stock. Some traders anticipate a continued rally, while others suggest caution due to overbought conditions and potential government actions.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community anticipates the release of GDP data provided by Pyth. There is also speculation about potential allocations from other projects, like $DJT, with some users suggesting connections to other trending coins. The community is also actively discussing potential price movements and future adoption.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community speculates about upcoming partnership announcements and a potential integration with traditional payroll systems. Discussions revolve around the potential for real-world utility and the impact of regulatory compliance, like MiCA, on Zebec's growth. Some traders are watching key support levels, while others express frustration with sideways price action.

Firecoin is a digital asset inspired by the concept of the eternal flame, representing energy, resilience, and guidance. It is designed to act as a decentralized token that embodies light and strength, giving holders a sense of empowerment in the digital economy. The project’s purpose is to create a community-driven ecosystem where Firecoin symbolizes progress, illumination, and the ability to move forward regardless of challenges. By leveraging blockchain technology, Firecoin aims to provide transparency, security, and accessibility to its users while maintaining its thematic connection to the symbolic power of fire.

firecoin

FIRECOIN.X is trending as community members signal their conviction with repeated "I am IN" declarations and calls to "BUY." The enthusiasm suggests many believe FIRECOIN.X is primed for a substantial move, potentially outperforming other tokens on the Solana blockchain.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp ($UAMY) is trending amid discussions of its recent $245 million defense contract, which has significantly altered the company's financial outlook. Community members highlight the potential for a short squeeze given the stock's high short interest and anticipate further catalysts, including potential government grants and equity stakes. Some traders are drawing parallels to $MP's performance after securing a similar government contract, suggesting a bullish outlook for UAMY.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron (MU) is trending following its earnings report, with the community actively debating whether the positive results and guidance justify the recent surge in stock price. Community members are weighing the potential for further gains against profit-taking, with some analysts raising price targets, while others anticipate a pullback. Discussions also highlight Micron's positioning in the AI sector and its competitive edge in HBM technology.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401JK.X is trending as community members rally behind its narrative of disrupting traditional retirement plans. Fueling the conversation is the token's recent performance and the community's shared goal of achieving early retirement by mocking the system. The coin's limited supply and strong community engagement are also being highlighted as key factors for its potential.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as retail traders eye further gains, drawing comparisons to Nvidia and Google's YTD performance. Community discussion revolves around the momentum in quantum computing, with some highlighting the company's partnerships and others questioning its valuation relative to revenue. Recent news of government contracts may be contributing to the bullish sentiment.

ETF Series Solutions Trust - Defiance Quantum ETF

Defiance Quantum ETF ($QTUM) is trending as the quantum computing sector gains attention, with some news outlets suggesting it's outperforming major tech stocks. The ETF's holdings in quantum computing companies like Rigetti and IonQ are driving community interest. Some investors view $QTUM as a promising long-term investment in disruptive technology, while others discuss specific price targets and potential competitor ETFs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zai Lab (ZLAB) announced on Wednesday that it plans to await the results of a trial evaluating Bemarituzumab in combination with Nivolumab and chemotherapy before filing for regulatory approval for the experimental cancer drug.The data from the trial is expected by the end of 2025 or the first half of 2026, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0903/2025090302254.pdf">said</a> in a filing with the Hong Kong stock exchange. Nasdaq-listed <a href="https://stocktwits.com/symbol/ZLAB">shares of Zai Lab</a> were down 4% at the time of writing.On Stocktwits, retail sentiment around ZLAB stayed within ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.The announcement from the company follows its partner Amgen's (AMGN) completion of the final analysis of the late-stage trial evaluating Bemarituzumab in combination with Chemotherapy in first-line gastric cancer.Amgen <a href="https://stocktwits.com/news-articles/markets/equity/amgen-cancer-drug-improves-survival-in-late-stage-trial/chmZZAcRR79">said</a> in late June that Bemarituzumab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival as compared to placebo plus chemotherapy in people living with certain types of unresectable locally advanced or metastatic gastric or gastroesophageal junction cancer. Overall survival refers to the total length of time a patient with cancer remains alive after diagnosis or the initiation of treatment.However, Zai Lab said on Wednesday that, upon final analysis of the trial, the magnitude of the previously observed survival benefit was reduced, leading the company to await the results of another trial.Zai Lab holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.ZLAB shares are up 22% this year and approximately 66% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/ford-reports-near-four-percent-jump-in-us-vehicle-sales-in-august/chwT6RHRd8r">Ford Reports Near 4% Jump In US Vehicle Sales In August</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Zai Lab company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug

The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.

Equity

The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.


Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings

The headline numbers for Zai Lab Limited (ZLAB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?

Zai Lab Limited (ZLAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its fourth quarter and full year 2024 financial results and provide recent corporate updates on February 27, 2025...

Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly active first-in-class...

Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that Chinas National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for KarXT for the treatment of...

Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced positive topline results from the China subpopulation of the global Phase 3 innovaTV 301 study, demonstrating a clinically meaningful...

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced an exclusive collaboration and license agreement for the development and...

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the development and...

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a new strategic collaboration and worldwide license agreement with MediLink Therapeutics (Suzhou) Co., Ltd. (MediLink) to use MediLinks...

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Zai Lab Limited - ADR

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

ZLAB
Zai Lab Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZLAB News

ZLAB Zai Lab Ltd